Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecast to 2027

管腔内縫合デバイスのグローバル市場予測(~2027):肥満手術、消化器手術、胃食道逆流症手術、その他手術

◆タイトル:Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecast to 2027
◆商品コード:MD8153-22
◆調査・発行会社:MarketsandMarkets
◆発行日:2022年8月19日
◆ページ数:143
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社の最新調査レポートによると、世界の管腔内縫合デバイス市場規模は、2022年78百万ドルから2027年139百万ドルまで年平均12.0%成長すると推定されます。当書は、管腔内縫合デバイスの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、用途別(肥満手術、消化器手術、胃食道逆流症手術、その他手術)分析、エンドユーザー別(病院、クリニック、外来手術センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況、企業情報などについて総合的にまとめています。なお、当書に掲載されている企業情報には、Apollo Endosurgery, Inc. (US)、Johnson & Johnson (US)、Medtronic Plc (Ireland)、Cook Group Incorporated (US)、USGI Medical (US)、Ovesco Endoscopy AG (Germany)、Endo Tools Therapeutics S.A. (Belgium)、ErgoSuture (US)、Sutrue Ltd. (UK)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の管腔内縫合デバイス市場規模:用途別
- 肥満手術用管腔内縫合デバイスの市場規模
- 消化器手術用管腔内縫合デバイスの市場規模
- 胃食道逆流症手術用管腔内縫合デバイスの市場規模
- その他手術用管腔内縫合デバイスの市場規模
・世界の管腔内縫合デバイス市場規模:エンドユーザー別
- 病院における市場規模
- クリニックにおける市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の管腔内縫合デバイス市場規模:地域別
- 北米の管腔内縫合デバイス市場規模
- ヨーロッパの管腔内縫合デバイス市場規模
- アジア太平洋の管腔内縫合デバイス市場規模
- 中南米の管腔内縫合デバイス市場規模
- 中東・アフリカの管腔内縫合デバイス市場規模
・競争状況
・企業情報

“The global endoluminal suturing devices market is projected to reach USD 139 million by 2027 from USD 78 million in 2022, at a CAGR of 12.0%.”
The growth of this market can largely be attributed to the rising demand for bariatric surgeries, increasing number of surgeries, and rising prevalence of gastrointestinal diseases.

“The gastrointestinal surgery segment is expected to register the highest CAGR during the forecast period”
Based on application, the global endoluminal suturing devices market is segmented into bariatric surgery, gastrointestinal surgery, gastroesophageal reflux disease surgery, and other surgeries. The gastrointestinal surgery segment is expected to register the highest growth during the forecast period. This is mainly due to the growing number of gastrointestinal cancer cases worldwide.

“The ambulatory care centers segment to witness the highest growth in the endoluminal suturing devices end user market during the forecast period”
Based on end users, the endoluminal suturing devices market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users. The ambulatory care centers segment is expected to register the highest growth during the forecast period. This can be attributed to the increased adoption of getting treated in ambulatory care settings due to the cost-effective treatment offered.

“The APAC to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022–2027. The presence of high-growth markets such as India, China, and Japan, rapidly developing healthcare industry in China and India, increasing number of hospitals, rising per capita income, increasing healthcare infrastructure, rising burden of GI cancer, and the rising awareness about health are some of the major factors that are expected to drive the growth of the endoluminal suturing devices market in the Asia Pacific region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–40%, Europe–30%, Asia Pacific–20%, Latin America- 5%, Middle East and Africa–5%

Key players in the Endoluminal suturing devices market
The prominent players in the endoluminal suturing devices market are Apollo Endosurgery, Inc. (US), Johnson & Johnson (US), Medtronic Plc (Ireland), Cook Group Incorporated (US), USGI Medical (US), Ovesco Endoscopy AG (Germany), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (US), and Sutrue Ltd. (UK).

Research Coverage:
The report analyzes the endoluminal suturing devices market and aims at estimating the market size and future growth potential of this market based on various segments such as, application, and end user. The report also includes a product portfolio matrix of various endoluminal suturing devices available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the endoluminal suturing devices market. The report analyzes this market by application and by end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global endoluminal suturing devices market.
• Market Development: Comprehensive information on the lucrative emerging markets by application and by end user.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoluminal suturing devices market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoluminal suturing devices market.

【レポートの目次】

1 INTRODUCTION 20
1.1 STUDY OBJECTIVES 20
1.2 MARKET DEFINITION 20
1.2.1 INCLUSIONS & EXCLUSIONS 20
1.2.2 MARKETS COVERED 21
FIGURE 1 ENDOLUMINAL SUTURING DEVICES MARKET SEGMENTATION 21
1.2.3 YEARS CONSIDERED 21
1.3 CURRENCY CONSIDERED 22
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 22
1.4 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH APPROACH 23
2.2 RESEARCH DESIGN 23
FIGURE 2 ENDOLUMINAL SUTURING DEVICES MARKET: RESEARCH DESIGN 23
2.2.1 SECONDARY RESEARCH 24
2.2.1.1 Key data from secondary sources 25
2.2.2 PRIMARY DATA 25
FIGURE 3 PRIMARY SOURCES 26
2.2.2.1 Key data from primary sources 27
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 27
2.3 MARKET SIZE ESTIMATION 28
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 28
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION 29
FIGURE 7 TOP-DOWN APPROACH 29
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30
FIGURE 9 CAGR PROJECTIONS 31
2.4 DATA TRIANGULATION APPROACH 32
FIGURE 10 DATA TRIANGULATION METHODOLOGY 32
2.5 MARKET SHARE ESTIMATION 33
2.6 ASSUMPTIONS 33
2.7 LIMITATIONS 33
2.7.1 METHODOLOGY-RELATED LIMITATIONS 33
2.7.2 SCOPE-RELATED LIMITATIONS 34
2.8 RISK ASSESSMENT 34
TABLE 2 RISK ASSESSMENT: ENDOLUMINAL SUTURING DEVICES MARKET 34

3 EXECUTIVE SUMMARY 35
FIGURE 11 ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 35
FIGURE 12 ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 36
FIGURE 13 GEOGRAPHIC SNAPSHOT OF ENDOLUMINAL SUTURING DEVICES MARKET 37
4 PREMIUM INSIGHTS 38
4.1 ENDOLUMINAL SUTURING DEVICES MARKET OVERVIEW 38
FIGURE 14 RISING NUMBER OF SURGICAL PROCEDURES PERFORMED TO DRIVE GROWTH 38
4.2 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION AND COUNTRY (2021) 39
FIGURE 15 GASTROINTESTINAL SURGERIES ACCOUNTED FOR LARGEST SHARE
OF ASIA PACIFIC MARKET IN 2021 39
4.3 ENDOLUMINAL SUTURING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 40
FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 40
4.4 ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION (2020–2027) 41
FIGURE 17 NORTH AMERICA TO DOMINATE ENDOLUMINAL SUTURING DEVICES MARKET IN 2027 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
FIGURE 18 ENDOLUMINAL SUTURING DEVICES MARKET: KEY DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
5.2.1 DRIVERS 43
5.2.1.1 Increasing number of surgical procedures worldwide 43
TABLE 3 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2020 43
5.2.1.2 Rising prevalence of gastrointestinal cancers, inflammatory bowel disease, and other digestive diseases 44
TABLE 4 GLOBAL INCIDENCE OF COLORECTAL CANCER, 2020 45
TABLE 5 GLOBAL GASTROINTESTINAL CANCER INCIDENCE, 2020 45
5.2.1.3 Favorable reimbursement scenario 45
5.2.2 RESTRAINTS 46
5.2.2.1 Presence of alternative wound care management products 46
5.2.3 OPPORTUNITIES 46
5.2.3.1 High-growth opportunities in emerging markets 46
TABLE 6 AVERAGE SURGICAL PROCEDURE COSTS (2021) 46
5.2.3.2 Increasing adoption of outpatient surgeries 47
5.2.4 CHALLENGES 47
5.2.4.1 Shortage of skilled personnel 47

5.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 48
TABLE 7 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 48
5.4 REGULATORY ANALYSIS 49
5.4.1 NORTH AMERICA 49
5.4.1.1 US 49
TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION 49
TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50
5.4.1.2 Canada 50
TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50
5.4.2 EUROPE 50
5.4.3 ASIA PACIFIC 51
5.4.3.1 Japan 51
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 51
5.4.3.2 China 51
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 52
5.4.3.3 India 52
5.5 PORTER’S FIVE FORCES ANALYSIS 52
TABLE 13 PORTER’S FIVE FORCES ANALYSIS 52
5.5.1 THREAT FROM NEW ENTRANTS 53
5.5.2 THREAT FROM SUBSTITUTES 53
5.5.3 BARGAINING POWER OF SUPPLIERS 53
5.5.4 BARGAINING POWER OF BUYERS 54
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 54
5.6 VALUE CHAIN ANALYSIS 54
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE 55
5.7 INDUSTRY TRENDS 55
5.7.1 MINIMALLY INVASIVE SURGERY 55
5.8 TECHNOLOGY ANALYSIS 56
5.8.1 ROBOTIC SUTURING SYSTEMS 56
5.9 ECOSYSTEM ANALYSIS 56
FIGURE 20 SURGICAL SUTURES MARKET: ECOSYSTEM MAP (2021) 56
5.10 PATENT ANALYSIS 57
5.10.1 PATENT PUBLICATION TRENDS FOR ENDOLUMINAL SUTURING DEVICES 57
FIGURE 21 PATENT PUBLICATION TRENDS (JANUARY 2011–JULY 2022) 57
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 57
FIGURE 22 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ENDOLUMINAL SUTURING DEVICES (JANUARY 2011–JULY 2022) 58
FIGURE 23 TOP APPLICANT JURISDICTIONS FOR ENDOLUMINAL SUTURING DEVICE PATENTS (JANUARY 2011–JULY 2022) 59
TABLE 14 LIST OF PATENTS IN ENDOLUMINAL SUTURING DEVICES MARKET,
2020–2022 59
6 ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION 61
6.1 INTRODUCTION 62
TABLE 15 ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 62
6.2 BARIATRIC SURGERY 62
6.2.1 GROWING PREVALENCE OF OBESITY TO DRIVE MARKET GROWTH 62
TABLE 16 NUMBER OF BARIATRIC SURGERIES PERFORMED GLOBALLY (2018) 63
TABLE 17 US: NUMBER OF BARIATRIC SURGERIES, 2011–2020 64
TABLE 18 ENDOLUMINAL SURGICAL DEVICES MARKET FOR BARIATRIC SURGERY,
BY COUNTRY, 2020–2027 (USD THOUSAND) 64
6.3 GASTROINTESTINAL SURGERY 65
6.3.1 GROWING BURDEN OF COLON CANCER TO INCREASE DEMAND FOR GASTROINTESTINAL SURGERY 65
TABLE 19 ESTIMATED NEW GI CANCER CASES AND DEATHS IN US, 2021 66
TABLE 20 ENDOLUMINAL SURGICAL DEVICES MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2020–2027 (USD THOUSAND) 67
6.4 GASTROESOPHAGEAL REFLUX DISEASE SURGERY 67
6.4.1 IMPROVING DIETS AND LIFESTYLE CHANGES TO RESTRAIN MARKET GROWTH 67
TABLE 21 ENDOLUMINAL SURGICAL DEVICES MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE SURGERY, BY COUNTRY, 2020–2027 (USD THOUSAND) 68
6.5 OTHER SURGERIES 68
TABLE 22 ENDOLUMINAL SURGICAL DEVICES MARKET FOR OTHER SURGERIES,
BY COUNTRY, 2020–2027 (USD THOUSAND) 69
7 ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER 70
7.1 INTRODUCTION 71
TABLE 23 ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD MILLION) 71
7.2 HOSPITALS 71
7.2.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO PROPEL MARKET GROWTH 71
TABLE 24 NUMBER OF HOSPITALS, BY COUNTRY, 2010–2021 72
TABLE 25 ENDOLUMINAL SUTURING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD THOUSAND) 73
7.3 CLINICS 73
7.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS—
KEY ADVANTAGES DRIVING MARKET GROWTH 73
TABLE 26 ENDOLUMINAL SUTURING DEVICES MARKET FOR CLINICS, BY COUNTRY, 2020–2027 (USD THOUSAND) 74
7.4 AMBULATORY SURGERY CENTERS 74
7.4.1 COST-EFFECTIVE TREATMENTS IN AMBULATORY CENTERS TO DRIVE DEMAND FOR THESE FACILITIES 74
TABLE 27 ENDOLUMINAL SUTURING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020–2027 (USD THOUSAND) 75
7.5 OTHER END USERS 76
TABLE 28 ENDOLUMINAL SUTURING DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2020–2027 (USD THOUSAND) 77
8 ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION 78
8.1 INTRODUCTION 79
FIGURE 24 ENDOLUMINAL SUTURING DEVICES MARKET: GEOGRAPHIC SNAPSHOT (2021) 79
TABLE 29 ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 80
8.2 NORTH AMERICA 80
TABLE 30 NORTH AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 80
FIGURE 25 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET SNAPSHOT 81
TABLE 31 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 82
TABLE 32 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 82
TABLE 33 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND) 83
8.2.1 US 83
8.2.1.1 US to dominate North American endoluminal suturing devices market during forecast period 83
TABLE 34 US: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 84
TABLE 35 US: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND) 84
TABLE 36 US: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 85
8.2.2 CANADA 85
8.2.2.1 Increasing volume of surgeries to fuel demand for endoluminal suturing devices in Canada 85
TABLE 37 CANADA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS,
AND FIVE-YEAR PREVALENCE (2020) 86
TABLE 38 CANADA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 86
TABLE 39 CANADA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 86
8.3 EUROPE 87
TABLE 40 EUROPE: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 87
TABLE 41 EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY,
2020–2027 (USD THOUSAND) 87
TABLE 42 EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 88
TABLE 43 EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 88
8.3.1 GERMANY 89
8.3.1.1 High penetration of health insurance makes Germany largest market for endoluminal suturing devices in Europe 89
TABLE 44 GERMANY: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 89
TABLE 45 GERMANY: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 90
TABLE 46 GERMANY: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020–2027 (USD THOUSAND) 90
8.3.2 FRANCE 91
8.3.2.1 Well-established healthcare system and growing procedural volume boost market growth 91
TABLE 47 FRANCE: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 91
TABLE 48 FRANCE: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 92
8.3.3 UK 92
8.3.3.1 Growing volume of hernia repair and bowel cancer surgeries will stimulate market growth 92
TABLE 49 UK: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 92
TABLE 50 UK: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND) 93
TABLE 51 UK: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 93
8.3.4 ITALY 94
8.3.4.1 Initiatives to build awareness about digestive health to increase adoption of endoluminal suturing devices 94
TABLE 52 ITALY: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 94
TABLE 53 ITALY: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND) 95
TABLE 54 ITALY: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 95
8.3.5 SPAIN 95
8.3.5.1 Growing healthcare budget to drive growth in Spain 95
TABLE 55 SPAIN: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 96
TABLE 56 SPAIN: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 96
TABLE 57 SPAIN: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 97
8.3.6 REST OF EUROPE 97
TABLE 58 REST OF EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 98
TABLE 59 REST OF EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND) 98

8.4 ASIA PACIFIC 99
TABLE 60 ASIA PACIFIC: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 99
FIGURE 26 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET SNAPSHOT 100
TABLE 61 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 101
TABLE 62 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 101
TABLE 63 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020–2027 (USD THOUSAND) 102
8.4.1 JAPAN 102
8.4.1.1 Strong healthcare system in Japan supports growth of endoluminal suturing devices market 102
TABLE 64 JAPAN: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 103
TABLE 65 JAPAN: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 103
TABLE 66 JAPAN: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 104
8.4.2 CHINA 104
8.4.2.1 Growing number of hospitals and increased prevalence of obesity to propel growth in China 104
TABLE 67 CHINA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 105
TABLE 68 CHINA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 105
TABLE 69 CHINA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 105
8.4.3 INDIA 106
8.4.3.1 Increasing prevalence of gastrointestinal disorders and favorable government support to drive market in India 106
TABLE 70 INDIA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 106
TABLE 71 INDIA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND) 107
TABLE 72 INDIA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 107
8.4.4 REST OF ASIA PACIFIC 108
TABLE 73 REST OF ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 108
TABLE 74 REST OF ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND) 109
8.5 LATIN AMERICA 109
8.5.1 GROWING MEDICAL TOURISM IN LATIN AMERICAN COUNTRIES TO PROPEL MARKET 109
TABLE 75 LATIN AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 110
TABLE 76 BRAZIL: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 110
TABLE 77 LATIN AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 110
TABLE 78 LATIN AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020–2027 (USD THOUSAND) 111
8.6 MIDDLE EAST & AFRICA 111
8.6.1 MIDDLE EAST & AFRICA—SMALLEST REGIONAL MARKET FOR ENDOLUMINAL SUTURING DEVICES 111
TABLE 79 MIDDLE EAST & AFRICA: GASTROINTESTINAL CANCER INCIDENCE (2020) 111
TABLE 80 MIDDLE EAST & AFRICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 112
TABLE 81 MIDDLE EAST & AFRICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND) 112
9 COMPETITIVE LANDSCAPE 113
9.1 OVERVIEW 113
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 113
9.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 113
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN ENDOLUMINAL SUTURING DEVICES MARKET 114
9.4 MARKET SHARE ANALYSIS 114
FIGURE 28 ENDOLUMINAL SUTURING DEVICES MARKET SHARE, BY KEY PLAYER, 2021 114
TABLE 82 ENDOLUMINAL SUTURING DEVICES MARKET: DEGREE OF COMPETITION 115
9.5 COMPETITIVE BENCHMARKING 116
TABLE 83 ENDOLUMINAL SUTURING DEVICES MARKET: COMPETITIVE BENCHMARKING 116
9.6 COMPANY FOOTPRINT 117
TABLE 84 FOOTPRINT OF COMPANIES IN ENDOLUMINAL SUTURING DEVICES MARKET 117
9.6.1 APPLICATION FOOTPRINT 117
TABLE 85 APPLICATION FOOTPRINT OF COMPANIES 117
9.6.2 END-USER FOOTPRINT 118
TABLE 86 END-USER FOOTPRINT OF COMPANIES 118
9.6.3 REGIONAL FOOTPRINT 118
TABLE 87 REGIONAL FOOTPRINT OF COMPANIES 118
9.7 COMPANY EVALUATION QUADRANT 119
9.7.1 STARS 119
9.7.2 EMERGING LEADERS 119
9.7.3 PERVASIVE PLAYERS 119
9.7.4 PARTICIPANTS 119
FIGURE 29 ENDOLUMINAL SUTURING DEVICES MARKET: COMPANY EVALUATION QUADRANT (2021) 120
9.8 COMPETITIVE SCENARIO 121
9.8.1 PRODUCT LAUNCHES 121
TABLE 88 PRODUCT LAUNCHES (JANUARY 2019–JULY 2022) 121
9.8.2 OTHER DEVELOPMENTS 121
TABLE 89 OTHER DEVELOPMENTS (JANUARY 2019–JULY 2022) 121
10 COMPANY PROFILES 122
10.1 KEY PLAYERS 122
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1 APOLLO ENDOSURGERY, INC. 122
TABLE 90 APOLLO ENDOSURGERY, INC.: BUSINESS OVERVIEW 122
FIGURE 30 APOLLO ENDOSURGERY, INC.: COMPANY SNAPSHOT (2021) 123
10.1.2 JOHNSON & JOHNSON (ETHICON, INC.) 125
TABLE 91 JOHNSON & JOHNSON: BUSINESS OVERVIEW 125
FIGURE 31 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021) 126
10.1.3 MEDTRONIC PLC 128
TABLE 92 MEDTRONIC, INC.: BUSINESS OVERVIEW 128
FIGURE 32 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 129
10.1.4 COOK GROUP INCORPORATED 131
TABLE 93 COOK GROUP INCORPORATED: BUSINESS OVERVIEW 131
10.1.5 USGI MEDICAL 133
TABLE 94 USGI MEDICAL: BUSINESS OVERVIEW 133
10.1.6 OVESCO ENDOSCOPY AG 135
TABLE 95 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW 135
10.1.7 ENDO TOOLS THERAPEUTICS S.A. 136
TABLE 96 ENDO TOOLS THERAPEUTICS S.A.: BUSINESS OVERVIEW 136
10.1.8 ERGOSUTURE 137
TABLE 97 ERGOSUTURE: BUSINESS OVERVIEW 137
10.1.9 SUTRUE LTD. 138
TABLE 98 SUTRUE LTD.: BUSINESS OVERVIEW 138
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11 APPENDIX 139
11.1 INSIGHTS FROM INDUSTRY EXPERTS 139
11.2 DISCUSSION GUIDE 140
11.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143
11.4 CUSTOMIZATION OPTIONS 145
11.5 RELATED REPORTS 145
11.6 AUTHOR DETAILS 146



★調査レポート[管腔内縫合デバイスのグローバル市場予測(~2027):肥満手術、消化器手術、胃食道逆流症手術、その他手術] ( Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecast to 2027 / MD8153-22) 販売に関する免責事項
[管腔内縫合デバイスのグローバル市場予測(~2027):肥満手術、消化器手術、胃食道逆流症手術、その他手術] ( Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecast to 2027 / MD8153-22) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆